Cargando…
A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy
Background: Chemotherapy is suggested to use in all stages of pancreatic cancer. Is it reasonable to recommend chemotherapy for all PDAC patients? It is necessary to distinguish low-risk PDAC patients underwent pancreatectomy, who may not lose survival time due to missed chemotherapy and not need to...
Autores principales: | Li, Yuqiang, Tian, Mengxiang, Zhou, Yuan, Tan, Fengbo, Liu, Wenxue, Zhao, Lilan, Perez, Daniel, Song, Xiangping, Wang, Dan, Nitschke, Christine, Pei, Qian, Güngör, Cenap |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176415/ https://www.ncbi.nlm.nih.gov/pubmed/34093844 http://dx.doi.org/10.7150/jca.57768 |
Ejemplares similares
-
The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision
por: Xu, Biaoxiang, et al.
Publicado: (2022) -
Accurate nomograms with excellent clinical value for locally advanced rectal cancer
por: Li, Yuqiang, et al.
Publicado: (2021) -
Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis
por: Wang, Dan, et al.
Publicado: (2020) -
The survival impact of radiotherapy on synchronous metastatic rectal cancer: metastatic site can serve for radiotherapy-decision
por: Zhou, Yuan, et al.
Publicado: (2022) -
The Survival Effect of Radiotherapy on Stage IIB/III Pancreatic Cancer Undergone Surgery in Different Age and Tumor Site Groups: A Propensity Scores Matching Analysis Based on SEER Database
por: Wang, Dan, et al.
Publicado: (2022)